Literature DB >> 25698127

Occurrence and predictors of the fatigue in high-grade glioma patients.

Irene Aprile1, Silvia Chiesa, Luca Padua, Chiara Di Blasi, Maria Felice Arezzo, Vincenzo Valentini, Enrico Di Stasio, Mario Balducci.   

Abstract

A better knowledge of the fatigue could be of the greatest importance for the high-grade glioma (HGG) patients, who are a unique and vulnerable population. The aim of this study was to evaluate the occurrence and the predictors of the fatigue in HGG patients, using a specific fatigue scale. The study was designed as a cross-sectional study. The study population included sixty-seven consecutive outpatients with HGG. We used these measures: Brief Fatigue Inventory, Karnofsky Performance Scale, Functional Independence Measure, Brief Psychiatric Rating Scale and Psychological Distress Inventory and SF-36, EORTC QLQ-30 and EORTC QLQ-BN20 for quality of life (QoL). Sixteen out of sixty-seven (23.9 %) patients were affected by Anaplastic Astrocytoma and 51/67 (76.1 %) by Glioblastoma Multiforme. About one-third (36.2 %) of patients had a clinically relevant fatigue (Brief Fatigue Inventory ≥3). In regression analysis, physical and mental aspects of QoL were statistically significant related with fatigue (p < 0.01 and p < 0.02, respectively). Our data underlined the relevant occurrence of fatigue in HGG patients and support the development of further studies exploring a tailored rehabilitation program.

Entities:  

Mesh:

Year:  2015        PMID: 25698127     DOI: 10.1007/s10072-015-2111-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

1.  Fatigue patterns observed in patients receiving chemotherapy and radiotherapy.

Authors:  A L Schwartz; L M Nail; S Chen; P Meek; A M Barsevick; M E King; L S Jones
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

2.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

5.  Fatigue, pain, and depression in pre-autotransplant breast cancer patients.

Authors:  F Gaston-Johansson; J M Fall-Dickson; A B Bakos; M J Kennedy
Journal:  Cancer Pract       Date:  1999 Sep-Oct

6.  Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.

Authors:  Kimberly R Porter; Usha Menon; Nicholas A Vick; John L Villano; Michael L Berbaum; Faith G Davis
Journal:  Support Care Cancer       Date:  2014-01-03       Impact factor: 3.603

7.  Effect of disease burden on health-related quality of life in patients with malignant gliomas.

Authors:  D Osoba; M Brada; M D Prados; W K Yung
Journal:  Neuro Oncol       Date:  2000-10       Impact factor: 12.300

Review 8.  Cancer pain, fatigue, distress, and insomnia in cancer patients.

Authors:  Dale E Theobald
Journal:  Clin Cornerstone       Date:  2004

9.  Clinically relevant fatigue in recurrence-free prostate cancer survivors.

Authors:  D J Storey; D B McLaren; M A Atkinson; I Butcher; S Liggatt; R O'Dea; J F Smyth; M Sharpe
Journal:  Ann Oncol       Date:  2011-03-24       Impact factor: 32.976

10.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; A J Fischbach; C H Chang; M Rotman; S O Asbell; R E Krisch
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

View more
  7 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Symptom-based interventions to promote quality survivorship.

Authors:  Christina Amidei
Journal:  Neuro Oncol       Date:  2018-11-09       Impact factor: 12.300

3.  Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy.

Authors:  Claudia Bitterlich; Dirk Vordermark
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

4.  Screening for distress in patients with intracranial tumors during the first 6 months after diagnosis using self-reporting instruments and an expert rating scale (the basic documentation for psycho-oncology short form - PO-Bado SF).

Authors:  Mirjam Renovanz; Helena Tsakmaklis; Sari Soebianto; Isabell Neppel; Minou Nadji-Ohl; Manfred Beutel; Andreas Werner; Florian Ringel; Anne-Katrin Hickmann
Journal:  Oncotarget       Date:  2018-07-24

5.  Prevalence and correlates of fatigue in patients with meningioma before and after surgery.

Authors:  Sophie D van der Linden; Karin Gehring; Geert-Jan M Rutten; Willem J Kop; Margriet M Sitskoorn
Journal:  Neurooncol Pract       Date:  2019-06-27

6.  Supportive Care Needs in Glioma Patients and Their Caregivers in Clinical Practice: Results of a Multicenter Cross-Sectional Study.

Authors:  Mirjam Renovanz; Dorothea Maurer; Heike Lahr; Elke Weimann; Monika Deininger; Christian Rainer Wirtz; Florian Ringel; Susanne Singer; Jan Coburger
Journal:  Front Neurol       Date:  2018-09-11       Impact factor: 4.003

7.  Factors Influencing the Improvement of Activities of Daily Living during Inpatient Rehabilitation in Newly Diagnosed Patients with Glioblastoma Multiforme.

Authors:  Keisuke Natsume; Harutoshi Sakakima; Kentaro Kawamura; Akira Yoshida; Shintaro Akihiro; Hajime Yonezawa; Koji Yoshimoto; Megumi Shimodozono
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.